# Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome

> **NCT00760084** · PHASE2 · COMPLETED · sponsor: **Eisai Inc.** · enrollment: 10 (actual)

## Conditions studied

- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Decitabine

## Key facts

- **NCT ID:** NCT00760084
- **Lead sponsor:** Eisai Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2005-09
- **Final completion:** 2008-02
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2011-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00760084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00760084, "Trial of Decitabine in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndrome". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00760084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*